<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Merck &amp; Co. Inc.</title><link>https://investorshangout.com/Merck--Co-Inc-MRK-51867/</link><description><![CDATA[Merck & Co. Inc. (MRK)]]></description><language>en-us</language><pubDate>Wed, 21 Oct 2026 15:54:03 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Merck--Co-Inc-MRK-51867/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $MRK News Article - Merck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference </title><link>https://investorshangout.com/post/view?id=6659505</link><guid>https://investorshangout.com/post/view?id=6659505</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 03 Jan 2024 16:55:46 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - KEYTRUDA (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improv</title><link>https://investorshangout.com/post/view?id=6634969</link><guid>https://investorshangout.com/post/view?id=6634969</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 20 Oct 2023 18:10:47 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck &amp; Co Inc. (NYSE: MRK) Highlighted for Surprising Price Action </title><link>https://investorshangout.com/post/view?id=6611478</link><guid>https://investorshangout.com/post/view?id=6611478</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 23 Aug 2023 17:55:53 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - KEYTRUDA (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survi</title><link>https://investorshangout.com/post/view?id=6546926</link><guid>https://investorshangout.com/post/view?id=6546926</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 10 Mar 2023 15:25:48 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck&#039;s Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Min</title><link>https://investorshangout.com/post/view?id=6545083</link><guid>https://investorshangout.com/post/view?id=6545083</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 06 Mar 2023 18:10:47 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck&#039;s KEYTRUDA (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Prog</title><link>https://investorshangout.com/post/view?id=6531431</link><guid>https://investorshangout.com/post/view?id=6531431</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 03 Feb 2023 13:30:44 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Lung Cancer Market To Grow Steadily With An Impressive CAGR Of 14.4% From 2022 T</title><link>https://investorshangout.com/post/view?id=6531430</link><guid>https://investorshangout.com/post/view?id=6531430</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 03 Feb 2023 13:25:46 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Enters Definitive Agreement to Acquire Imago Biosciences </title><link>https://investorshangout.com/post/view?id=6501503</link><guid>https://investorshangout.com/post/view?id=6501503</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 21 Nov 2022 21:50:50 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - How Long Can This Top Stock Continue Defying the Bear Market? </title><link>https://investorshangout.com/post/view?id=6499958</link><guid>https://investorshangout.com/post/view?id=6499958</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 17 Nov 2022 19:50:52 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Is Merck Too Dependent on Keytruda? </title><link>https://investorshangout.com/post/view?id=6496058</link><guid>https://investorshangout.com/post/view?id=6496058</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 09 Nov 2022 18:10:51 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - European Commission Expands Merck&#039;s VAXNEUVANCE(TM) (Pneumococcal 15-valent Conj</title><link>https://investorshangout.com/post/view?id=6488845</link><guid>https://investorshangout.com/post/view?id=6488845</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 24 Oct 2022 16:15:50 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Guggenheim Upgraded the Merck Stock to Buy, Noting the Company&#039;s Projected Profi</title><link>https://investorshangout.com/post/view?id=6482946</link><guid>https://investorshangout.com/post/view?id=6482946</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 10 Oct 2022 19:25:50 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck (MRK) Stock Jumps 4% on Positive Trial Data </title><link>https://investorshangout.com/post/view?id=6482916</link><guid>https://investorshangout.com/post/view?id=6482916</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 10 Oct 2022 18:40:47 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Announces Positive Top-line Results from Pivotal Phase 3 STELLAR Trial Eva</title><link>https://investorshangout.com/post/view?id=6482743</link><guid>https://investorshangout.com/post/view?id=6482743</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 10 Oct 2022 14:40:49 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Animal Health to Acquire Vence </title><link>https://investorshangout.com/post/view?id=6474751</link><guid>https://investorshangout.com/post/view?id=6474751</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 22 Sep 2022 15:20:47 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - What Stocks To Buy Today? 5 Dividend Stocks To Watch In This Bear Market </title><link>https://investorshangout.com/post/view?id=6436091</link><guid>https://investorshangout.com/post/view?id=6436091</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 11 Jul 2022 18:25:51 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Investors Shake off Hot Inflation Report </title><link>https://investorshangout.com/post/view?id=6401118</link><guid>https://investorshangout.com/post/view?id=6401118</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 11 May 2022 20:10:55 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - European Commission Approves Merck&#039;s KEYTRUDA (pembrolizumab) as Adjuvant Thera</title><link>https://investorshangout.com/post/view?id=6330161</link><guid>https://investorshangout.com/post/view?id=6330161</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 27 Jan 2022 19:00:54 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort </title><link>https://investorshangout.com/post/view?id=6314675</link><guid>https://investorshangout.com/post/view?id=6314675</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 05 Jan 2022 18:46:16 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - European Commission Approves Merck&#039;s VAXNEUVANCE(TM) (Pneumococcal 15-valent Con</title><link>https://investorshangout.com/post/view?id=6302376</link><guid>https://investorshangout.com/post/view?id=6302376</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 15 Dec 2021 17:45:50 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Why You Can&#039;t Afford Not to Buy Merck&#039;s Stock </title><link>https://investorshangout.com/post/view?id=6288932</link><guid>https://investorshangout.com/post/view?id=6288932</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 23 Nov 2021 20:05:50 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Techs, S&amp;P Tumble to Start Week </title><link>https://investorshangout.com/post/view?id=6255189</link><guid>https://investorshangout.com/post/view?id=6255189</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 04 Oct 2021 19:40:49 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - A Glimpse of This Week&#039;s Earnings Calendar </title><link>https://investorshangout.com/post/view?id=6255176</link><guid>https://investorshangout.com/post/view?id=6255176</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 04 Oct 2021 19:25:48 GMT</pubDate></item><item><title>znewcar1: That&#039;s awesome! MRK Monday!</title><link>https://investorshangout.com/post/view?id=6254155</link><guid>https://investorshangout.com/post/view?id=6254155</guid><description><![CDATA[znewcar1
]]></description><pubDate>Sat, 02 Oct 2021 13:07:36 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - &quot;The Buzz&quot; Show: Merck (NYSE: MRK) Positive Data in Covid-19 Antiviral Drug Tria</title><link>https://investorshangout.com/post/view?id=6253884</link><guid>https://investorshangout.com/post/view?id=6253884</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 01 Oct 2021 19:55:54 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Novavax News: Why NVAX Stock Investors Have a Tough Pill to Swallow Today </title><link>https://investorshangout.com/post/view?id=6253610</link><guid>https://investorshangout.com/post/view?id=6253610</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 01 Oct 2021 16:35:51 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - ACCELERON PHARMA ALERT: Bragar Eagel &amp; Squire, P.C. Investigates Sale of XLRN an</title><link>https://investorshangout.com/post/view?id=6253576</link><guid>https://investorshangout.com/post/view?id=6253576</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 01 Oct 2021 16:05:51 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Dr Gottlieb on Merck&#039;s oral COVID-19 drug: &#039;it&#039;s a profound game changer&#039; </title><link>https://investorshangout.com/post/view?id=6253421</link><guid>https://investorshangout.com/post/view?id=6253421</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 01 Oct 2021 14:25:49 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Announces Appointment of Thomas H. Glocer as Independent Lead Director </title><link>https://investorshangout.com/post/view?id=6252007</link><guid>https://investorshangout.com/post/view?id=6252007</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 29 Sep 2021 20:10:49 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Top Biotech Stocks To Watch In October 2021 </title><link>https://investorshangout.com/post/view?id=6251888</link><guid>https://investorshangout.com/post/view?id=6251888</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 29 Sep 2021 18:45:49 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Completes Acquisition of Themis </title><link>https://investorshangout.com/post/view?id=5800867</link><guid>https://investorshangout.com/post/view?id=5800867</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 19 Jun 2020 19:35:41 GMT</pubDate></item><item><title>EmergingGrowth: Zero Waste: https://emerginggrowth.com/itronics-inc-itro-nevada-grown-internationally-recognized</title><link>https://investorshangout.com/post/view?id=5797890</link><guid>https://investorshangout.com/post/view?id=5797890</guid><description><![CDATA[EmergingGrowth
]]></description><pubDate>Wed, 17 Jun 2020 13:05:39 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - FDA Accepts For Review Supplemental New Drug Application (sNDA) for RECARBRIO(TM</title><link>https://investorshangout.com/post/view?id=5663467</link><guid>https://investorshangout.com/post/view?id=5663467</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 03 Feb 2020 21:55:41 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Is Merck Still a Strong Buy? </title><link>https://investorshangout.com/post/view?id=5658122</link><guid>https://investorshangout.com/post/view?id=5658122</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 29 Jan 2020 21:45:43 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck&#039;s KEYTRUDA (pembrolizumab) Approved in Japan for Three New First-Line Ind</title><link>https://investorshangout.com/post/view?id=5624773</link><guid>https://investorshangout.com/post/view?id=5624773</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 20 Dec 2019 17:05:43 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck&#039;s KEYTRUDA (pembrolizumab) Now Approved in China for First-Line Treatment</title><link>https://investorshangout.com/post/view?id=5603547</link><guid>https://investorshangout.com/post/view?id=5603547</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 26 Nov 2019 21:20:42 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats Receives Ap</title><link>https://investorshangout.com/post/view?id=5593417</link><guid>https://investorshangout.com/post/view?id=5593417</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 15 Nov 2019 18:05:42 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Fires on All Cylinders in Q3 With Soaring Sales for Keytruda </title><link>https://investorshangout.com/post/view?id=5578066</link><guid>https://investorshangout.com/post/view?id=5578066</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 29 Oct 2019 19:45:43 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Dow Jones News: Walmart Under Pressure From Amazon; Merck Trounces Analyst Estim</title><link>https://investorshangout.com/post/view?id=5578051</link><guid>https://investorshangout.com/post/view?id=5578051</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 29 Oct 2019 19:35:45 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck &amp; Co Inc (MRK) Q3 2019 Earnings Call Transcript </title><link>https://investorshangout.com/post/view?id=5578048</link><guid>https://investorshangout.com/post/view?id=5578048</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 29 Oct 2019 19:30:41 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - S&amp;P to Slip From Record High </title><link>https://investorshangout.com/post/view?id=5577840</link><guid>https://investorshangout.com/post/view?id=5577840</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 29 Oct 2019 16:40:41 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference </title><link>https://investorshangout.com/post/view?id=5552181</link><guid>https://investorshangout.com/post/view?id=5552181</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 30 Sep 2019 17:40:45 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck&#039;s KEYTRUDA (pembrolizumab) in Combination with Chemotherapy Met Primary E</title><link>https://investorshangout.com/post/view?id=5495478</link><guid>https://investorshangout.com/post/view?id=5495478</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 29 Jul 2019 17:20:41 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - European Medicines Agency Adopts Positive Opinion for Merck&#039;s KEYTRUDA (pembrol</title><link>https://investorshangout.com/post/view?id=5495472</link><guid>https://investorshangout.com/post/view?id=5495472</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 29 Jul 2019 17:15:40 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Foundation Announces Grant to American Cancer Society to Improve Access to</title><link>https://investorshangout.com/post/view?id=5443524</link><guid>https://investorshangout.com/post/view?id=5443524</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 22 May 2019 18:35:40 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck Announces First-Quarter 2019 Financial Results </title><link>https://investorshangout.com/post/view?id=5425919</link><guid>https://investorshangout.com/post/view?id=5425919</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 30 Apr 2019 18:05:40 GMT</pubDate></item><item><title>whytestocks: $MRK News Article - Merck and Viola Davis to Debut A Touch of Sugar During Tribeca Film Festival </title><link>https://investorshangout.com/post/view?id=5422492</link><guid>https://investorshangout.com/post/view?id=5422492</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 25 Apr 2019 18:30:42 GMT</pubDate></item><item><title>riddock57: $MRK and $LLY To Test New Combo For Soft Tissue Sarcoma </title><link>https://investorshangout.com/post/view?id=4288197</link><guid>https://investorshangout.com/post/view?id=4288197</guid><description><![CDATA[riddock57
]]></description><pubDate>Fri, 13 Jan 2017 02:42:20 GMT</pubDate></item><item><title>Lucky Jimmy: MRK up +1.49% percent Today $MRK Stock High is at 53.26 and the Low 52.67 with current volume of 1,6</title><link>https://investorshangout.com/post/view?id=3460199</link><guid>https://investorshangout.com/post/view?id=3460199</guid><description><![CDATA[Lucky Jimmy
]]></description><pubDate>Tue, 05 Jan 2016 16:49:08 GMT</pubDate></item><item><title>Hattlem: MRK buying Sirna Theraputics a baby in the RNAi field at the time it was purchased. Sirna traded on </title><link>https://investorshangout.com/post/view?id=3459025</link><guid>https://investorshangout.com/post/view?id=3459025</guid><description><![CDATA[Hattlem
]]></description><pubDate>Tue, 05 Jan 2016 10:38:36 GMT</pubDate></item></channel></rss>